文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

四种保留括约肌技术治疗肛瘘的失败率和并发症:一项系统评价和网状Meta分析

Failure rates and complications of four sphincter-sparing techniques for the treatment of fistula-in-ano: a systematic review and network meta-analysis.

作者信息

Fuschillo G, Pata F, D'Ambrosio M, Selvaggi L, Pescatori M, Selvaggi F, Pellino G

机构信息

Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania "Luigi Vanvitelli," Policlinico CS, Piazza Miraglia 2, 80138, Naples, Italy.

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

出版信息

Tech Coloproctol. 2025 May 20;29(1):116. doi: 10.1007/s10151-025-03152-0.


DOI:10.1007/s10151-025-03152-0
PMID:40392371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12092498/
Abstract

BACKGROUND: Several techniques are available to reduce the risk of sphincter injury when treating anal fistula, such as ligation of the intersphincteric fistula tract (LIFT), video-assisted anal fistula treatment (VAAFT), fistula laser closure (FiLaC) and endoanal flap (EAF). The aim of this meta-analysis is to provide data on the safety, complications and failure of these techniques. METHODS: Studies published after 2017, with patients undergoing at least one among LIFT, VAAFT, FiLaC and EAF for perianal fistula and providing data regarding failure, were retrieved from PubMed and EMBASE. Primary outcome was failure; other outcomes included continence disturbance and complications. RESULTS: Forty-nine articles with 3520 patients were included. The failure rates were 28.6% (range 3.8-75) for LIFT, 22.3% (6.2-65.2) for VAAFT, 43.9% (11.1-80) for FiLaC and 25.9% (4.7-100) for EAF, with a mean follow-up of 35.4 (6-80.4), 32.4 (6-48), 31.6(6.3-60) and 42.4 (12-155) months. The available network meta-analysis on failure showed RD of -0.08 (95% CI - 0.58 to 0.42) comparing LIFT vs VAAFT and 0.30 (95% CI 0.03 to 0.58) comparing LIFT vs EAF. No patients undergoing VAAFT or FiLaC reported worsening continence, while for LIFT and EAF, the continence disturbance rate was 1.5% and 7.3%, respectively. No major complications were observed. The most common minor complications were pain (1.4%), bleeding (1.1%) and wound infection (1.2%). Overall, minor complication rates were 4.3% for LIFT, 7.2% for VAAFT, 10.2% for FiLaC and 6.2% for EAF. Crohn's disease was associated with a higher failure rate (39.5% vs 31.4%). CONCLUSIONS: FiLaC, VAAFT, LIFT and EAF may represent a valid option in the treatment of anal fistula. VAAFT showed the lowest rate of failure but with no differences from network metanalysis. Wider homogeneous studies with long-term follow-up are necessary to obtain more robust data. PROSPERO NUMBER: CRD42022375600.

摘要

背景:在治疗肛瘘时,有多种技术可降低括约肌损伤风险,如括约肌间瘘管结扎术(LIFT)、视频辅助肛瘘治疗(VAAFT)、肛瘘激光闭合术(FiLaC)和肛管皮瓣术(EAF)。本荟萃分析的目的是提供这些技术的安全性、并发症及失败率的数据。 方法:从PubMed和EMBASE检索2017年后发表的研究,这些研究纳入了接受LIFT、VAAFT、FiLaC和EAF中至少一种治疗肛周瘘且提供失败相关数据的患者。主要结局是失败;其他结局包括控便障碍和并发症。 结果:纳入49篇文章,共3520例患者。LIFT的失败率为28.6%(范围3.8 - 75),VAAFT为22.3%(6.2 - 65.2),FiLaC为43.9%(11.1 - 80),EAF为25.9%(4.7 - 100),平均随访时间分别为35.4(6 - 80.4)、32.4(6 - 48)、31.6(6.3 - 60)和42.4(12 - 155)个月。关于失败的可用网状荟萃分析显示,比较LIFT与VAAFT时RD为 - 0.08(95%CI - 0.58至0.42),比较LIFT与EAF时为0.30(95%CI 0.03至0.58)。接受VAAFT或FiLaC治疗的患者均未报告控便能力恶化,而LIFT和EAF的控便障碍率分别为1.5%和7.3%。未观察到严重并发症。最常见的轻微并发症是疼痛(1.4%)、出血(1.1%)和伤口感染(1.2%)。总体而言,LIFT的轻微并发症发生率为4.3%,VAAFT为7.2%,FiLaC为10.2%,EAF为6.2%。克罗恩病与较高的失败率相关(39.5%对31.4%)。 结论:FiLaC、VAAFT、LIFT和EAF可能是治疗肛瘘的有效选择。VAAFT显示出最低的失败率,但与网状荟萃分析无差异。需要更广泛的同质研究及长期随访以获得更可靠的数据。 PROSPERO编号:CRD42022375600。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/eac0fba69c7d/10151_2025_3152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/da149597dbe0/10151_2025_3152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/7088e1938bf3/10151_2025_3152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/1c2a954258f1/10151_2025_3152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/10e9e6b5049a/10151_2025_3152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/e169280e633c/10151_2025_3152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/eac0fba69c7d/10151_2025_3152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/da149597dbe0/10151_2025_3152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/7088e1938bf3/10151_2025_3152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/1c2a954258f1/10151_2025_3152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/10e9e6b5049a/10151_2025_3152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/e169280e633c/10151_2025_3152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec2/12092498/eac0fba69c7d/10151_2025_3152_Fig6_HTML.jpg

相似文献

[1]
Failure rates and complications of four sphincter-sparing techniques for the treatment of fistula-in-ano: a systematic review and network meta-analysis.

Tech Coloproctol. 2025-5-20

[2]
Short-term efficacy and safety of three novel sphincter-sparing techniques for anal fistulae: a systematic review.

Tech Coloproctol. 2017-10-29

[3]
Lift and VAAFT for high trans-sphincteric anal fistula: a single center retrospective analysis.

Int J Colorectal Dis. 2020-6

[4]
Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study.

J Crohns Colitis. 2020-7-9

[5]
Perianal fistulas and the lift procedure: results, predictive factors for success, and long-term results with subsequent treatment.

Tech Coloproctol. 2019-7-17

[6]
Sphincter-saving therapy for fistula-in-ano: long-term follow-up after FiLaC.

Tech Coloproctol. 2021-2

[7]
Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.

BJS Open. 2019-1-21

[8]
A systematic review and meta-analysis of the safety and efficacy of fistula laser closure.

Tech Coloproctol. 2020-4

[9]
Video-assisted anal fistula treatment for complex anorectal fistulas in adults: a systematic review and meta-analysis.

Tech Coloproctol. 2022-10

[10]
Management of complex anorectal fistulas with seton drainage plus partial fistulotomy and subsequent ligation of intersphincteric fistula tract (LIFT).

Tech Coloproctol. 2014-11-18

本文引用的文献

[1]
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.

J Crohns Colitis. 2024-10-15

[2]
Predictors of recurrence and long-term patient reported outcomes following surgical repair of anal fistula, a retrospective analysis.

Int J Colorectal Dis. 2024-3-11

[3]
Ligation of Intersphincteric Fistulous Tract vs Endorectal Advancement Flap for High-Type Fistula in Ano: A Randomized Controlled Trial.

J Am Coll Surg. 2023-1-1

[4]
Vaaft (Video Assisted Anal Fistula Treatment); Novel Technique For The Treatment Of Anal Fistula.

J Ayub Med Coll Abbottabad. 2022

[5]
Outcomes in High Perianal Fistula Repair Using Video-Assisted Anal Fistula Treatment Compared With Seton Use: A Randomized Controlled Trial.

Cureus. 2022-2-13

[6]
Increasing experience with the LIFT procedure in Crohn's disease patients with complex anal fistula.

Tech Coloproctol. 2022-3

[7]
Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes.

Clin Exp Gastroenterol. 2021-12-6

[8]
Video-assisted anal fistula treatment versus fistulectomy and sphincter repair in the treatment of high cryptoglandular anal fistula: a randomized clinical study.

BJS Open. 2021-9-6

[9]
Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence.

BMC Med Res Methodol. 2021-9-20

[10]
VAAFT for complex anal fistula: a useful tool, however, cure is unlikely.

Tech Coloproctol. 2021-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索